C12Y 304/21031
Urokinase
Official title: Urokinase (3.4.21.31) (C12Y304/21068, C12Y304/21073 take precedence)
C12Y304/21031 (Urokinase) appears on 11 US grants and 23 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 23
- Assignees
- 13
- Inventors
- 37
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 3 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 3 |
| 2021 | 2 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 2 |
| 2024 | 2 | 4 |
| 2025 | 1 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Medical use of icaritin24 Feb 2026US 12,558,343 B2Lunan Pharmaceutical Group Corporation
- Peptide directed protein knockdown30 Sep 2025US 12,428,456 B2The University of British Columbia
- Drug regimen for treatment of cerebral ischemia8 Oct 2024US 12,109,265 B2Shimojani, LLC
- Method of treating acute coronary syndrome20 Aug 2024US 12,066,443 B2Alfred Health
- Peptide directed protein knockdown30 Nov 2021US 11,186,620 B2The University of British Columbia
- Use of Tetramethylpyrazine Nitrone Derivatives In The Treatment of Ischemic Stroke4 Jun 2026US 2026/0151389 A1Guangzhou Magpie Pharmaceuticals Co., Ltd.
- Targeting and lysing microthrombi associated with aberrant blood clotting7 May 2026US 2026/0125665 A1
- Target-specific thrombolytic urokinase microspheres and method to dissolve sickle disease clots11 Sep 2025US 2025/0281411 A1
- Drug regimen for treatment of cerebral ischemia26 Dec 2024US 2024/0424093 A1Shimojani, LLC
- Thrombolytic microspheres to dissolve vaso-occlusive clots12 Dec 2024US 2024/0408017 A1
Most cited
By later US patents
- Long-acting composition230US 4,609,546 AJapan Chemical Research Co., Ltd. · 1986
- Lung volume reduction using glue composition32US 7,553,810 B2PneumRx, Inc. · 2009
- Drug regimen for treatment of cerebral ischemia14US 11,077,188 B2Shimojani, LLC · 2021
- Peptide directed protein knockdown3US 10,287,333 B2The University of British Columbia · 2019
- Drug regimen for treatment of cerebral ischemia3US 10,617,756 B2Shimojani, LLC · 2020